IL23A and inflammatory bowel disease: Similarly, in the Helicobacter hepaticus infection model of IBD, expression of IL-23 was primarily restricted to CD64+ myeloid cells, and specific knockout of IL-23p19 expression in CD11c cells, which also express CD64, led to a striking reduction in the severity of colitis (34, 35).